[HTML][HTML] Overall survival benefit with tebentafusp in metastatic uveal melanoma

P Nathan, JC Hassel, P Rutkowski… - … England Journal of …, 2021 - Mass Medical Soc
Background Uveal melanoma is a disease that is distinct from cutaneous melanoma, with a
low tumor mutational burden and a 1-year overall survival of approximately 50% in patients …

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of …

S Kreher, S Ochsenreither, RU Trappe, I Pabinger… - Annals of …, 2014 - Springer
Patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) like
polycythemia vera and essential thrombocythemia are at increased risk of arterial and …

Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients

AG Chapuis, GB Ragnarsson, HN Nguyen… - Science translational …, 2013 - science.org
Relapse remains a leading cause of death after allogeneic hematopoietic cell
transplantation (HCT) for patients with high-risk leukemias. The potentially beneficial donor …

Three-year overall survival with tebentafusp in metastatic uveal melanoma

JC Hassel, S Piperno-Neumann… - … England Journal of …, 2023 - Mass Medical Soc
Background Tebentafusp, a T-cell receptor–bispecific molecule that targets glycoprotein 100
and CD3, is approved for adult patients who are positive for HLA-A* 02: 01 and have …

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck …

J Guigay, A Aupérin, J Fayette, E Saada-Bouzid… - The Lancet …, 2021 - thelancet.com
Background Results from a phase 2 trial of the TPEx chemotherapy regimen (docetaxel–
platinum–cetuximab) showed promising results, with a median overall survival of 14· 0 …

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double …

D Soulières, S Faivre, R Mesía, É Remenár… - The Lancet …, 2017 - thelancet.com
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation in squamous
cell carcinoma of the head and neck contributes to treatment resistance and disease …

[HTML][HTML] Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

C Tretter, N de Andrade Krätzig, M Pecoraro… - Nature …, 2023 - nature.com
Systemic pan-tumor analyses may reveal the significance of common features implicated in
cancer immunogenicity and patient survival. Here, we provide a comprehensive multi-omics …

[HTML][HTML] Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis

K Kuhls, L Keilonat, S Ochsenreither, M Schaar… - Microbes and …, 2007 - Elsevier
Multilocus enzyme electrophoresis (MLEE) is the gold standard for taxonomy and strain
typing of Leishmania, but has some limitations. An alternative reliable and fast genotyping …

Multilocus Microsatellite Typing as a New Tool for Discrimination of Leishmania infantum MON-1 Strains

S Ochsenreither, K Kuhls, M Schaar… - Journal of clinical …, 2006 - Am Soc Microbiol
The Leishmania donovani complex, which consists of L. donovani, L. infantum-L. chagasi,
and L. archibaldi, is responsible for visceral manifestations of leishmaniasis. Multilocus …

[HTML][HTML] Differentiation and Gene Flow among European Populations of Leishmania infantum MON-1

K Kuhls, C Chicharro, C Cañavate… - PLoS neglected …, 2008 - journals.plos.org
Background Leishmania infantum is the causative agent of visceral and cutaneous
leishmaniasis in the Mediterranean region, South America, and China. MON-1 L. infantum is …